Rifaximin (Xifaxan) + NAC: New & Improved SIBO Treatment with Dr. Mark Pimentel

This discussion centers on new research showing improved SIBO outcomes using N-acetylcysteine (NAC) in a special formulation with Rifaximin.

Clinical Observations and Outcomes

• Dr. Siebecker shares her experiences with NAC as an anti-biofilm, which did not yield significant success.
• This lack of observed efficacy led to the abandonment of this particular therapeutic strategy by the observing group.

The Importance of N-Acetylcysteine (NAC) Delivery

• N-acetylcysteine is recognized for its ability to break down mucus.
• A key challenge highlighted is that standard oral NAC can be quickly depleted by the mucus present in the stomach.
• For NAC to be effective in its intended site of action of the small intestine, for SIBO, it must bypass degradation in the stomach.
• Specialized delivery systems are thus a crucial factor that could differentiate outcomes, suggesting that the effectiveness of NAC combined with Rifaximin may depend heavily on how and where the NAC is delivered within the body.

Products mentioned: (affiliate links)

•   Jarrow Formulas N-A-C Sustain  600mg: Fullscript (with exclusive pricing) or Amazon
• Natures Plus PRO Sustained Release NAC (Amazon)